Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Raymond

Showing results (101-110 of 173) with videos related to

Pageof 18
Sort By:
Histology and Histopathology|May 10, 2014
Evidence for different expression profiles for c-Met, EGFR, PTEN and the mTOR pathway in low and high grade endometrial carcinomas in a cohort of consecutive women. Occurrence of PIK3CA and K-Ras mutations and microsatellite instabilityAnne Thoury, Véronique Descatoire, Larissa Kotelevets, et al.
Future Oncology (London, England)|May 16, 2019
Pharmacogenomic analyses of sunitinib in patients with pancreatic neuroendocrine tumorsNicola Fazio, Jean-Francois Martini, Adina E Croitoru, et al.
Molecular Cancer Therapeutics|April 17, 2008
Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cellsMaria Serova, Aïda Ghoul, Karim A Benhadji, et al.
JAMA Dermatology|October 2, 2013
Clinical activity of lenalidomide in visceral human immunodeficiency virus-related Kaposi sarcomaMaud Steff, Véronique Joly, Julie Di Lucca, et al.
Surgery|December 17, 2008
Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?Frédérique Maire, Pascal Hammel, Reza Kianmanesh, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 6, 2019
Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effectsHafidha Bentayeb, Marine Aitamer, Barbara Petit, et al.
Cancer Chemotherapy and Pharmacology|September 25, 2013
Differential regulation of sunitinib targets predicts its tumor-type-specific effect on endothelial and/or tumor cell apoptosisGuilhem Bousquet, Mariana Varna, Irmine Ferreira, et al.
Hepatology (Baltimore, Md.)|January 21, 2014
Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signatureGabriel G Malouf, Sylvie Job, Valérie Paradis, et al.
Molecular Cancer Therapeutics|July 14, 2011
Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cellsKatherine S Lovejoy, Maria Serova, Ivan Bieche, et al.
Frontiers in Chemistry|May 14, 2014
Cancer wars: natural products strike backChristine Basmadjian, Qian Zhao, Embarek Bentouhami, et al.
Pageof 18

Showing results (101-110 of 173) with videos related to

Sort By:
Pageof 18
Histology and Histopathology|May 10, 2014
Evidence for different expression profiles for c-Met, EGFR, PTEN and the mTOR pathway in low and high grade endometrial carcinomas in a cohort of consecutive women. Occurrence of PIK3CA and K-Ras mutations and microsatellite instabilityAnne Thoury, Véronique Descatoire, Larissa Kotelevets, et al.
Future Oncology (London, England)|May 16, 2019
Pharmacogenomic analyses of sunitinib in patients with pancreatic neuroendocrine tumorsNicola Fazio, Jean-Francois Martini, Adina E Croitoru, et al.
Molecular Cancer Therapeutics|April 17, 2008
Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cellsMaria Serova, Aïda Ghoul, Karim A Benhadji, et al.
JAMA Dermatology|October 2, 2013
Clinical activity of lenalidomide in visceral human immunodeficiency virus-related Kaposi sarcomaMaud Steff, Véronique Joly, Julie Di Lucca, et al.
Surgery|December 17, 2008
Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?Frédérique Maire, Pascal Hammel, Reza Kianmanesh, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 6, 2019
Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effectsHafidha Bentayeb, Marine Aitamer, Barbara Petit, et al.
Cancer Chemotherapy and Pharmacology|September 25, 2013
Differential regulation of sunitinib targets predicts its tumor-type-specific effect on endothelial and/or tumor cell apoptosisGuilhem Bousquet, Mariana Varna, Irmine Ferreira, et al.
Hepatology (Baltimore, Md.)|January 21, 2014
Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signatureGabriel G Malouf, Sylvie Job, Valérie Paradis, et al.
Molecular Cancer Therapeutics|July 14, 2011
Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cellsKatherine S Lovejoy, Maria Serova, Ivan Bieche, et al.
Frontiers in Chemistry|May 14, 2014
Cancer wars: natural products strike backChristine Basmadjian, Qian Zhao, Embarek Bentouhami, et al.
Pageof 18